Watch signals
Freshness and reclassification risk are surfaced as review prompts, not autonomous reclassification.
Tynixa
Scientific Governance Intelligence
Research Intelligence
Research-facing view of Review Intelligence: watch signals, scientific debate, route intelligence, Ask Tynixa explanation, and pilot value metrics.
Safety boundary: synthetic/de-identified only, no PHI, no raw patient identifiers, no final diagnosis, no final ACMG, no treatment recommendation, no clinical release, and qualified human review is required.
Scientific debate
Supporting and skeptical views are shown as draft review context.
Ask Tynixa
Explains the current room only; cannot export, assign reviewers, or finalize clinical decisions.
Next step
Use this route to inspect de-identified evidence/research context, then request a controlled pilot if the workflow fits. This page is a wrapper over existing Tynixa capabilities, not a new autonomous clinical decision system.
Request pilot